Kesselheim AS - Search Results

1

A cross-national comparison of 17 countries' insulin glargine drug labels.

Polinski JM, Kesselheim AS, Seeger JD, Connolly JG, Choudhry NK, Shrank WH. Polinski JM, et al. Among authors: kesselheim as. Pharmacoepidemiol Drug Saf. 2015 Feb;24(2):159-65. doi: 10.1002/pds.3704. Epub 2014 Sep 24. Pharmacoepidemiol Drug Saf. 2015. PMID: 25250724

2

The variability and quality of medication container labels.

Shrank WH, Agnew-Blais J, Choudhry NK, Wolf MS, Kesselheim AS, Avorn J, Shekelle P. Shrank WH, et al. Among authors: kesselheim as. Arch Intern Med. 2007 Sep 10;167(16):1760-5. doi: 10.1001/archinte.167.16.1760. Arch Intern Med. 2007. PMID: 17846395

3

The international pharmaceutical market as a source of low-cost prescription drugs for U.S. patients.

Kesselheim AS, Choudhry NK. Kesselheim AS, et al. Ann Intern Med. 2008 Apr 15;148(8):614-9. doi: 10.7326/0003-4819-148-8-200804150-00006. Ann Intern Med. 2008. PMID: 18413623

4

Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis.

Kesselheim AS, Misono AS, Lee JL, Stedman MR, Brookhart MA, Choudhry NK, Shrank WH. Kesselheim AS, et al. JAMA. 2008 Dec 3;300(21):2514-26. doi: 10.1001/jama.2008.758. JAMA. 2008. PMID: 19050195 Free PMC article. Review.

5

Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis.

Kesselheim AS, Stedman MR, Bubrick EJ, Gagne JJ, Misono AS, Lee JL, Brookhart MA, Avorn J, Shrank WH. Kesselheim AS, et al. Drugs. 2010 Mar 26;70(5):605-21. doi: 10.2165/10898530-000000000-00000. Drugs. 2010. PMID: 20329806 Free PMC article. Review.

6

State generic substitution laws can lower drug outlays under Medicaid.

Shrank WH, Choudhry NK, Agnew-Blais J, Federman AD, Liberman JN, Liu J, Kesselheim AS, Brookhart MA, Fischer MA. Shrank WH, et al. Among authors: kesselheim as. Health Aff (Millwood). 2010 Jul;29(7):1383-90. doi: 10.1377/hlthaff.2009.0424. Health Aff (Millwood). 2010. PMID: 20606192 Free PMC article.

7

Where cost, medical necessity, and morality meet: should US government insurance programs pay for erectile dysfunction drugs?

Polinski JM, Kesselheim AS. Polinski JM, et al. Among authors: kesselheim as. Clin Pharmacol Ther. 2011 Jan;89(1):17-9. doi: 10.1038/clpt.2010.179. Clin Pharmacol Ther. 2011. PMID: 21170064

8

The consequences of requesting "dispense as written".

Shrank WH, Liberman JN, Fischer MA, Avorn J, Kilabuk E, Chang A, Kesselheim AS, Brennan TA, Choudhry NK. Shrank WH, et al. Among authors: kesselheim as. Am J Med. 2011 Apr;124(4):309-17. doi: 10.1016/j.amjmed.2010.11.020. Am J Med. 2011. PMID: 21435421

9

Conflict of interest in oncology publications: a survey of disclosure policies and statements.

Kesselheim AS, Lee JL, Avorn J, Servi A, Shrank WH, Choudhry NK. Kesselheim AS, et al. Cancer. 2012 Jan 1;118(1):188-95. doi: 10.1002/cncr.26237. Epub 2011 Jun 29. Cancer. 2012. PMID: 21717432 Free article.

10

Changes in direct-to-consumer pharmaceutical advertising following shifts from prescription-only to over-the-counter status.

Greene JA, Choudhry NK, Kesselheim AS, Brennan TA, Shrank W. Greene JA, et al. Among authors: kesselheim as. JAMA. 2012 Sep 12;308(10):973-5. doi: 10.1001/2012.jama.10647. JAMA. 2012. PMID: 22968881 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

718 results

Search Page